Back to top

Image: Bigstock

Accenture PLC (ACN) Earnings Preview

Read MoreHide Full Article

On Thursday, June 23rd, Accenture Plc (ACN - Free Report) will release its third-quarter fiscal 2016 earnings results. The company is currently a Zacks Rank #2 (Buy) and shares are up over 13% on the year.

In our latest live earnings preview, Dave Bartosiak took a look at Accenture’s past earnings results, its recent estimate revision activity, and everything else you need to know before the company reports. Dave also looked into some potential trade opportunities for investors looking to make a play on Accenture ahead of earnings.

ACN in Focus

Accenture Plc is a management consulting, technology services, and outsourcing company. Measured by revenues, Accenture is the world’s largest consulting company. The company works with major players in both the private sphere and the public sphere, and in recent years it has taken over jobs such as maintenance on HealthCare.gov and the Department of Defense’s health records project.

Accenture is coming off of a slight earnings surprise last quarter, as the company beat the Zacks Consensus Estimate by 13.56%. Over the trailing four quarters, ACN has beat on earnings three out four times by an average of 5.58%.

ACCENTURE PLC Price and EPS Surprise

ACCENTURE PLC Price and EPS Surprise | ACCENTURE PLC Quote

Heading into this earnings report, our Most Accurate Estimate for Accenture is a penny higher than the Zacks Consensus Estimate, giving the company an Earnings ESP of 0.71%. Companies with positive Earnings ESPs and a Zacks Rank #2 (Buy) or above are more likely to beat on earnings.

Accenture’s recent success is being propelled by a series of moves that the company has made to improve its product offerings. The company has added products in the analytics application space and invested heavily in digital and marketing capabilities.

Accenture has also recently teamed up with GE Healthcare, a division of General Electric (GE), to introduce a new offering to help improve medical claims processing and related cash flow for healthcare providers.

Accenture Plc Price, Consensus and EPS Surprise

Subscribe to our channel to be notified of future live streams. And make sure to check out our other videos for more stock information.

David Bartosiak is the editor of the Momentum Trader and Home Run Investor service. He has over a decade of experience in the financial services industry. He has traded forex, futures, stocks, and options. Mr. Bartosiak is a frequent guest on popular business news TV channels such as Bloomberg TV. He’s also the host of a light-hearted, Millennial-minded series of videos called “Trending Stocks.”

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Accenture PLC (ACN) - free report >>